Baillie Gifford & CO Accelerate Diagnostics, Inc Transaction History

Baillie Gifford & CO

  • $126 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
BUY
$7.99 - $15.0 $375 - $705
47 Added 12.67%
418 $3,000
Q4 2020

Feb 10, 2021
BUY
$7.04 - $11.7 $2,611 - $4,340
371 New
371 $3,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email